Magnetic Insight specializes in Magnetic Particle Imaging (MPI), a cutting-edge imaging technology that offers a non-radioactive alternative to traditional nuclear medicine. MPI utilizes magnetic tracers that can be detected over extended periods, addressing the limitations of radioactive tracers, which have a short lifespan and complicate logistics for healthcare providers. This innovative approach not only enhances the quality of imaging but also significantly reduces the risks associated with radioactivity for patients, making it a safer option for medical diagnostics.

The company is focused on advancing MPI systems for both preclinical and clinical applications, partnering with leading innovators in the field to expand the use of this technology. By providing improved imaging capabilities, Magnetic Insight aims to streamline the supply chain for medical imaging, ultimately benefiting patients, healthcare providers, and hospitals alike. Their commitment to developing MPI technology positions them at the forefront of a transformative shift in medical imaging practices.

United States

Magnetic Insight is developing solutions in Magnetic Particle Imaging (MPI), a new imaging modality that directly detects iron oxide nanoparticle tracers using time-varying magnetic fields. Because the tracer is not normally found in the body, MPI images have exceptional contrast and high sensitivity.

Magnetic Insight

Company Details